- Home
- BALY vs TNGX Comparison
BALY vs TNGX Comparison
Compare BALY & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BALY
- TNGX
- Stock Information
- Founded
- BALY 2004
- TNGX 2014
- Country
- BALY United States
- TNGX United States
- Employees
- BALY N/A
- TNGX N/A
- Industry
- BALY Hotels/Resorts
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- BALY Consumer Discretionary
- TNGX Health Care
- Exchange
- BALY Nasdaq
- TNGX Nasdaq
- Market Cap
- BALY 711.1M
- TNGX 735.0M
- IPO Year
- BALY N/A
- TNGX N/A
- Fundamental
- Price
- BALY $17.41
- TNGX $7.15
- Analyst Decision
- BALY Hold
- TNGX Strong Buy
- Analyst Count
- BALY 7
- TNGX 8
- Target Price
- BALY $18.00
- TNGX $15.14
- AVG Volume (30 Days)
- BALY 479.6K
- TNGX 902.1K
- Earning Date
- BALY 10-30-2024
- TNGX 11-06-2024
- Dividend Yield
- BALY N/A
- TNGX N/A
- EPS Growth
- BALY N/A
- TNGX N/A
- EPS
- BALY N/A
- TNGX N/A
- Revenue
- BALY $2,484,286,000.00
- TNGX $42,509,000.00
- Revenue This Year
- BALY $5.55
- TNGX $18.15
- Revenue Next Year
- BALY $3.75
- TNGX N/A
- P/E Ratio
- BALY N/A
- TNGX N/A
- Revenue Growth
- BALY 5.27
- TNGX 26.16
- 52 Week Low
- BALY $7.28
- TNGX $6.33
- 52 Week High
- BALY $18.00
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- BALY 56.07
- TNGX 42.73
- Support Level
- BALY $17.45
- TNGX $6.83
- Resistance Level
- BALY $17.56
- TNGX $7.47
- Average True Range (ATR)
- BALY 0.15
- TNGX 0.35
- MACD
- BALY -0.03
- TNGX 0.14
- Stochastic Oscillator
- BALY 15.83
- TNGX 72.25
About BALY Bally's Corporation
Ballys Corp is a casino entertainment company with a growing omni-channel presence. It currently owns and manages 15 casinos across 10 states, a golf course in New York, a horse racetrack in Colorado, and has access to OSB licenses in 18 states. It also owns Bally's Interactive International, formerly Gamesys Group, a online gaming operator, Bally Bet, a sports betting platform, and Bally Casino, a iCasino platform. The Company's casino operations include approximately 15,300 slot machines, 580 table games, and 3,800 hotel rooms.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.